Increased age, male gender, and cirrhosis, but not steatosis or a positive viral serology, negatively impact the life expectancy of patients who undergo liver biopsy

Digestive Diseases and Sciences

Volumn 52, Issue 9, 2007, Pages 2276-2281

  Wachtel, Mitchell S ^a   Zhang, Yan ^b   Kaye, Kim E ^a   Chiriva Internati, Maurizio ^a   Frezza, Eldo E ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Chronic liver disease; Histopathology; Steatosis; Survival analysis; Viral serology

Indexed keywords

ARTICLE; CHRONIC LIVER DISEASE; DEMOGRAPHY; FATTY LIVER; FEMALE; FOLLOW UP; HAZARD ASSESSMENT; HUMAN; HUMAN TISSUE; LIFE EXPECTANCY; LIVER BIOPSY; LIVER CIRRHOSIS; LOG RANK TEST; MALE; MEDICAL ASSESSMENT; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SURVIVAL RATE; SURVIVAL TIME; VIRUS DETECTION;

ADULT; AGE FACTORS; BIOPSY; FATTY LIVER; FEMALE; FOLLOW-UP STUDIES; HEPATITIS ANTIBODIES; HEPATITIS VIRUSES; HEPATITIS, VIRAL, HUMAN; HUMANS; LIFE EXPECTANCY; LIVER; LIVER CIRRHOSIS; MALE; PREVALENCE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SURVIVAL RATE; UNITED STATES;

EID: 34547839680     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-9715-y     Document Type: Article

References (36)

1. Crook PD, Jones ME, Hall AJ (2003) Mortality of hepatitis B surface antigen-positive blood donors in England and Wales. Int J Epidemiol 32:118-124
2. Yuen MF, Yuan HJ, Wong DK, Yuen JC, Wong WM, Chan AO et al (2005) Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications. Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications. Gut 54:1610-1614
3. Harris HE, Ramsay ME, Andrews N, Eldridge KP; HCV National Register Steering Group (2002) Hepatitis C virus. Clinical course of hepatitis C virus during the first decade of infection: cohort study. BMJ 324(7335):450-453
4. Pokorski RJ (2000) Long-term insured lives morbidity and mortality risk associated with chronic hepatitis C virus infection. J Insur Med 32:226-248
5. Di Marco V, Lo Iacono O, Camma C, Vaccaro A, Giunta M, Martorana G et al (1999) The long-term course of chronic hepatitis B. Hepatology 30:257-264
6. Ong JP, Elariny H, Collantes R, Younoszai A, Chandhoke V, Reines HD et al (2005) Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients. Obes Surg 15:310-315
7. Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A et al (2005) The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129:113-121
8. Marrero JA (2006) Hepatocellular carcinoma. Curr Opin Gastroenterol 22:248-253
9. Motola-Kuba D, Zamora-Valdes D, Uribe M, Mendez-Sanchez N (2006) Hepatocellular carcinoma. An overview. Ann Hepatol 5:16-24
10. Bugianesi E (2005) Review article: steatosis, the metabolic syndrome and cancer. Aliment Pharmacol Ther 22(Suppl 2):40-43
11. Kojima H, Sakurai S, Matsumura M, Umemoto N, Uemura M, Morimoto H, et al (2006) Cryptogenic cirrhosis in the region where obesity is not prevalent. World J Gastroenterol 12:2080-2085
12. Clark JM (2006) The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol 40(Suppl 1):S5-S10
13. Bondini S, Younossi ZM (2006) Non-alcoholic fatty liver disease and hepatitis C infection. Minerva Gastroenterol Dietol 52:135-143
14. Yoon EJ, Hu KO (2006) Hepatitis C virus (HCV) infection and hepatic steatosis. Int J Med Sci 3:53-56
15. Bradbury MW (2006) Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: possible role in steatosis. Am J Physiol Gastrointest Liver Physiol 290:G194-G198
16. Powell EE, Ali A, Clouston AD, Dixon JL, Lincoln DJ, Purdie DM, et al (2005) Steatosis is a cofactor in liver injury in hemochromatosis. Gastroenterology 129:1937-1943
17. Powell EE, Jonsson JR, Clouston AD (2005) Steatosis: co-factor in other liver diseases. Hepatology 42:5-13
18. Ziolkowski A, Wylezol M, Kukla M, Zwirska-Korczala K, Berdowska A, Pardela M et al (2005) The comparison of scoring scales for liver biopsy assessment in morbidly obese patients undergoing bariatric surgery. Obes Surg 15:1309-1314
19. Thomopoulos KC, Arvaniti V, Tsamantas AC, Dimitropoulou D, Gogos CA, Siagris D et al (2006) Prevalence of liver steatosis in patients with chronic hepatitis B: a study of associated factors and of relationship with fibrosis. Eur J Gastroenterol Hepatol 18:233-237
20. Zafrani ES (2004) Non-alcoholic fatty liver disease: an emerging pathological spectrum. Virchows Arch 444:3-12
21. Mann RE, Smart RG, Govoni R (2003) The epidemiology of alcoholic liver disease. Alcohol Res Health 27:209-219
22. Gheorghe L, Iacob S, Simionov I, Vadan R, Gheorghe C, Iacob R et al (2005) Natural history of compensated viral B and D cirrhosis. Rom J Gastroenterol 14:329-335
23. Christmas AB, Wilson AK, Franklin GA, Miller FB, Richardson JD, Rodriguez JL (2005) Cirrhosis and trauma: a deadly duo. Am Surg 71:996-1000
24. Gildea TR, Cook WC, Nelson DR, Aggarwal A, Carey W, Younossi ZM et al (2004) Predictors of long-term mortality in patients with cirrhosis of the liver admitted to a medical ICU. Chest 126:1598-1603
25. Sanyal AJ, Banas C, Sargeant C, Luketic VA, Sterling RK, Stravitz RT (2006) Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C. Hepatology 43:682-689
26. Yoneyama K, Taniguchi H, Kiuchi Y, Shibata Y, Mitamura K (2004) Prognostic index of liver cirrhosis with ascites with and without hepatocellular carcinoma. Scand J Gastroenterol 39:1272-1279
27. Schlichting P, Christensen E, Andersen PK, Fauerholdt L, Juhl E, Poulsen H et al (1983) Prognostic factors in cirrhosis identified by Cox's regression model. Hepatology 3:889-895
28. D'Amico G, Morabito A, Pagliaro L, Marubini E (1986) Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci 31:468-475
29. Christensen E, Schlichting P, Andersen PK, Fauerholdt L, Schou G, Pedersen BV et al (1986) Updating prognosis and therapeutic effect evaluation in cirrhosis with Cox's multiple regression model for time-dependent variables. Scand J Gastroenterol 21:163-174
30. Foreman MG, Mannino DM, Moss M (2003) Cirrhosis as a risk factor for sepsis and death: analysis of the National Hospital Discharge Survey. Chest 124:1016-1020
31. Cholongitas E, Senzolo M, Patch D, Kwong K, Nikolopoulou V, Leandro G et al (2006) Risk factors, sequential organ failure assessment and model for end-stage liver disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit. Aliment Pharmacol Ther 23;883-893
32. Ravaioli M, Grazi GL, Ercolani G, Cescon M, Del Gaudio M, Zanello M et al (2006) Liver allocation for hepatocellular carcinoma: a European Center policy in the pre-MELD era. Transplantation 81:525-530
33. Adler M, De Gendt E, Vereerstraeten P, Degre D, Bourgeois N, Boon N et al (2005) Value of the MELD score for the assessment of pre- and post-liver transplantation survival. Transplant Proc 37:2863-2864
34. Ma H, Wang H, Sun Y, Guo F, Fang JL, Shao J et al (2005) [Analysis of prognosis of patients with decompensated liver cirrhosis using the criterion of the Model of End-Stage Liver Disease]. Zhonghua Gan Zang Bing Za Zhi 13:407-409
35. Papatheodoridis GV, Cholongitas E, Dimitriadou E, Touloumi G, Sevastianos V, Archimandritis AJ (2005) MELD vs Child-Pugh and creatinine-modified Child-Pugh score for predicting survival in patients with decompensated cirrhosis. World J Gastroenterol 11:3099-3104
36. R Development Core Team (2006) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http://www.R-project.org